Down Syndrome

Abstract

Down syndrome is a genetic condition caused by the presence of a third copy of chromosome 21 (trisomy 21), and it is the most common chromosomal cause of intellectual disability. Its interest for cognitive psychology lies less in the fact of impairment than in its *shape*: Down syndrome does not lower every cognitive ability uniformly but produces a distinctive, uneven profile in which some capacities — visuospatial short-term memory, receptive vocabulary, social understanding — are relative strengths, while others — verbal short-term memory, expressive grammar, and explicit long-term memory — are disproportionately weak. This article sets out the genetic mechanisms and this characteristic phenotype, traces it to the hippocampus and prefrontal cortex, follows it into the near-universal Alzheimer pathology of later life, and draws out what a *dissociable* profile tells the science of mind.

Keywords: trisomy 21, intellectual disability, cognitive phenotype, working memory

Down syndrome occupies a special place in cognitive psychology because it is a natural experiment in how a single, precisely specified genetic difference reshapes the mind. A person with Down syndrome carries an extra copy of one of the smallest human chromosomes, and from that one difference flows a pattern of cognitive strengths and weaknesses that is neither random nor uniform but *structured* — recognisable enough that researchers speak of a Down syndrome cognitive phenotype (Silverman, 2007). That structure is the reason the condition matters here: it shows that intelligence is not a single dial turned down, but a set of partly independent systems that a genetic cause can affect selectively (Dierssen, 2012).

The account below moves from what Down syndrome is and how trisomy 21 arises, through the uneven cognitive profile and its roots in memory and language, to the neuroanatomy that underlies it, its unfolding across development, and the tie between Down syndrome and Alzheimer's disease that has made the condition central to dementia research. The recurring theme is dissociation: within a single genetic condition, cognitive capacities that ordinary experience treats as one come conspicuously apart.

What Down Syndrome Is

Down syndrome is the clinical condition that results when a person carries three copies of chromosome 21 instead of the usual two. It is named for John Langdon Down, the English physician who gave the first systematic clinical description in 1866, though its cause remained unknown for almost a century until Jérôme Lejeune and colleagues identified the extra chromosome in 1959 (Mégarbané et al., 2009). It is the most common chromosomal disorder in humans and the most common genetic cause of intellectual disability, with a live-birth prevalence of roughly one in 700 (de Graaf, Buckley, Dever, & Skotko, 2017). The condition affects the whole body — characteristic facial features, congenital heart defects, hypotonia, and a raised risk of several medical conditions accompany it — but its defining feature for cognitive science is a consistent effect on the developing brain and mind (Bull, 2020).

The single most important idea for understanding Down syndrome cognitively is that it does *not* impair the mind uniformly. It is tempting to picture intellectual disability as a general dimming, every ability reduced by the same proportion, but this is precisely what the evidence contradicts. Instead, Down syndrome produces an *uneven cognitive profile*: against the background of a general lowering of measured intelligence, certain abilities stand out as relative strengths and others as disproportionate weaknesses (Chapman & Hesketh, 2000). This unevenness is the phenotype's most scientifically informative feature, because a genetic cause that affected a single, undifferentiated faculty of intelligence could not produce it — the pattern shows that the mind is built from separable components that trisomy 21 touches to different degrees (Silverman, 2007).

Because the extra chromosome is present from conception, Down syndrome is a *developmental* condition, not a static one. The profile is not fixed at birth but *emerges* over time, as the imbalance between systems that develop typically and systems that lag becomes more pronounced with age — a developmental trajectory that must be tracked across the lifespan rather than captured in a single snapshot (Karmiloff-Smith et al., 2016). Understanding Down syndrome therefore means understanding not only what the profile *is* at any moment but how it *comes to be* and how it changes from infancy into old age.

Core Features

The cognitive core of Down syndrome is its characteristic profile of relative strengths and weaknesses. On the strength side, *visuospatial* short-term memory — holding and reproducing the locations of objects — is comparatively well preserved, as is *receptive* vocabulary (the words a person understands), and many individuals show real social strengths in reading and responding to others (Silverman, 2007). On the weakness side, *verbal* short-term memory is disproportionately poor, *expressive* language (especially grammar and sentence production) lags well behind comprehension, and *explicit* long-term memory for facts and events is impaired more than the general level of ability would predict (Grieco, Pulsifer, Seligsohn, Skotko, & Schwartz, 2015).

The most heavily studied of these contrasts is the dissociation within short-term memory. On the working-memory model, verbal material is held in a *phonological loop* and visuospatial material in a separate store; in Down syndrome the phonological loop is specifically compromised while the visuospatial store is relatively intact (Jarrold & Baddeley, 2001). A person with Down syndrome will typically recall fewer spoken digits or words than a typically developing child of the same overall mental age, yet match that child on remembering spatial sequences — a double dissociation that pins the deficit to the verbal system rather than to memory in general (Jarrold, Baddeley, & Phillips, 2002). This single contrast has outsized importance because verbal short-term memory is a foundation for vocabulary growth and language learning, so a weakness there propagates into the broader language delay.

A second core feature is the dissociation between kinds of long-term memory. *Implicit* memory — the non-conscious learning expressed in skills, habits, and priming — is relatively spared, whereas *explicit* memory — the conscious recollection of facts and events that depends on the hippocampus — is disproportionately impaired (Vicari, Bellucci, & Carlesimo, 2000). This pattern, replicated across studies of memory across the lifespan, is one of the clearest windows onto the underlying neuroanatomy, because it maps directly onto the specific brain structures that trisomy 21 affects most (Godfrey & Lee, 2018).

Genetics and Mechanisms

Down syndrome is caused by *trisomy 21* — the presence of a third copy of chromosome 21, one of the smallest human chromosomes, whose complete DNA sequence was published in 2000 (Hattori et al., 2000). The extra chromosome means that the several hundred genes it carries are present in three copies rather than two, so their products are over-expressed by roughly 50%; the cognitive and physical phenotype is understood as the cumulative developmental consequence of this dosage imbalance across many genes rather than the effect of any single gene (Antonarakis et al., 2020). Which genes matter most, and how gene dosage translates into an altered brain, remains an active research question central to the whole field.

There are three genetic mechanisms by which the extra chromosome-21 material arises, and they differ in frequency and in how the extra copy is distributed. The great majority of cases — about 95% — are *free trisomy 21*, in which every cell carries a whole extra chromosome 21 because the chromosome pair failed to separate (nondisjunction) during formation of the egg or, less often, the sperm. A small proportion — around 3 to 4% — arise from a *Robertsonian translocation*, in which the extra chromosome-21 material is attached to another chromosome; some of these are inherited from a carrier parent. The remainder — about 1 to 2% — are *mosaic*, in which the nondisjunction happens after conception so that only some of the body's cells carry the extra chromosome (Roizen & Patterson, 2003).

The most robust epidemiological fact about the origin of trisomy 21 is its link to *maternal age*. Because the error that produces free trisomy 21 is usually a failure of chromosome separation in the egg, and because eggs have been arrested mid-division since before the mother's own birth, the risk of nondisjunction rises steeply with maternal age — from well under 1 in 1,000 for mothers in their twenties to more than 1 in 100 by the early forties (Antonarakis et al., 2020). This age relationship, quantified in the worked example below, is the single strongest predictor of the chance of conceiving a child with Down syndrome, though because more children are born to younger mothers overall, most children with Down syndrome are in fact born to mothers under 35.

Worked Example

The relationship between maternal age and the chance of Down syndrome is a good place to make the epidemiology concrete, because it is widely misunderstood and easy to reason about badly. The key quantities are two different probabilities that are often confused: the *maternal-age-specific risk* (the chance, for a mother of a given age, that a given pregnancy is affected) and the *distribution of births* across maternal ages (how many babies are actually born to mothers of each age). Both are needed to think clearly about the condition (de Graaf et al., 2017).

Consider the age-specific risk first. Approximate empirical figures place the chance at roughly 1 in 1,400 at maternal age 20, about 1 in 900 at age 30, near 1 in 350 at age 35, roughly 1 in 100 at age 40, and about 1 in 30 by age 45 (Antonarakis et al., 2020). The rise is not linear but accelerating: the increase from 30 to 35 roughly doubles the risk, but the increase from 40 to 45 more than triples it. This steep, accelerating curve is why maternal age has always been the central variable in prenatal risk counselling.

Now combine it with the second quantity, and a genuine paradox dissolves. Suppose — to illustrate the arithmetic — that in some population 80% of births are to mothers under 35, at an average risk of about 1 in 1,000, and 20% are to mothers 35 and over, at an average risk of about 1 in 200. Out of 100,000 births, the younger group contributes 80,000 × (1/1,000) = 80 affected children, while the older, higher-risk group contributes 20,000 × (1/200) = 100. The older group has five times the *per-pregnancy* risk, yet the two groups produce comparable *numbers* of affected children — and if the split toward younger mothers is steeper, most affected children are born to younger, lower-risk mothers. The lesson is that a high individual risk in a small group need not dominate the population total: rate and count answer different questions, and confusing them is a classic base-rate error.

Memory and Language

Language is where the uneven profile shows most plainly in everyday life, and its roots lie partly in memory. Across the profile, language *comprehension* consistently outstrips language *production*, and within production, *grammar* (morphology and syntax) lags behind *vocabulary* (Chapman & Hesketh, 2000). A person with Down syndrome may understand a spoken instruction well yet struggle to produce the grammatically complex sentence needed to reply, and this expressive-over-receptive gap widens with age rather than closing.

Part of this language pattern traces back to the verbal short-term memory weakness described above. The phonological loop — the system that briefly holds speech sounds — supports the learning of new word forms, so a specific impairment there plausibly constrains vocabulary acquisition and the learning of the sound patterns of grammar (Jarrold & Baddeley, 2001). Careful experiments have worked to separate whether the verbal memory deficit reflects a problem of memory storage itself, of *hearing* (many children with Down syndrome have hearing loss), or of *speech* output, and they locate a substantial part of it in the memory system rather than in audition or articulation alone (Jarrold et al., 2002).

The long-term memory dissociation compounds the picture. Because explicit, hippocampus-dependent memory is relatively impaired while implicit, procedural learning is relatively spared, individuals with Down syndrome often learn better through repeated, structured practice that builds habits than through instructions that demand conscious recall of facts — a contrast with clear educational implications and one that recurs consistently in reviews of memory across development (Godfrey & Lee, 2018). The verbal-versus-visuospatial and implicit-versus-explicit dissociations together explain a large part of why the profile takes the shape it does.

Neuroanatomy

The cognitive profile has a neuroanatomical counterpart. The brain in Down syndrome is smaller overall, but the reduction is not uniform: the *hippocampus*, the *prefrontal cortex*, and the *cerebellum* are disproportionately reduced in volume relative to the whole brain, while some other regions are relatively preserved (Dierssen, 2012). This regional pattern is not incidental — it lines up strikingly with the cognitive dissociations. The hippocampus is the structure most essential to explicit, relational memory, so its disproportionate under-development offers a direct anatomical account of why explicit memory is impaired while implicit, non-hippocampal learning is spared (Pennington, Moon, Edgin, Stedron, & Nadel, 2003).

This alignment of a specific memory deficit with a specific structure made Down syndrome an early and influential test case for the *biobehavioural* approach to genetic disorders — the strategy of predicting, from what is known about which brain systems a condition affects, exactly which cognitive functions should be impaired and which spared, and then testing those predictions (Nadel, 2003). The prediction that hippocampal dysfunction should produce a selective explicit-memory deficit, sparing implicit memory, was borne out, giving the field a model of how to reason from genotype through brain to cognition (Pennington et al., 2003).

At the cellular level, the trisomic brain shows altered neuronal density, reduced dendritic branching and spine number, and changes in the balance of excitation and inhibition — the microscopic substrate of the volume differences seen on imaging, and the level at which mouse models of trisomy have begun to connect specific gene-dosage effects to specific neural and behavioural consequences (Dierssen, 2012). Bridging these levels — from the genes present in triplicate, through altered neurons and circuits, to the cognitive profile — is the central explanatory project of the field.

Development Across the Lifespan

Down syndrome is a developmental condition, and its cognitive profile is best understood as a *trajectory* rather than a fixed state. In infancy the differences from typical development are relatively subtle, but the *rate* of cognitive growth is slower, so measured IQ, expressed relative to chronological age, tends to decline through childhood even as absolute abilities continue to grow (Karmiloff-Smith et al., 2016). The uneven profile itself emerges and sharpens over development: the gap between comprehension and production, and between visuospatial and verbal memory, becomes more pronounced with age, which is why a *developmental* framework — asking how the profile is constructed over time from early differences — is essential rather than optional (Edgin, 2013).

This developmental perspective carries an important warning against over-generalising. There is substantial *individual variability* among people with Down syndrome: the profile describes a central tendency, not a fixed template, and individuals differ widely in language, memory, and adaptive outcomes for reasons that include genetic background, health comorbidities, and environment (Karmiloff-Smith et al., 2016). Large cohort studies tracking cognition alongside health across the lifespan have made clear how much of the variation is bound up with co-occurring conditions — sensory, sleep, thyroid, and others — that are themselves treatable (Startin et al., 2020).

Across the adult years, and thanks to dramatic improvements in medical care, life expectancy in Down syndrome has risen from around 25 years in 1980s cohorts to about 60 today — a demographic transformation that has reframed the condition as a lifespan one and brought the cognition of *older* adults with Down syndrome to the centre of research (Bittles & Glasson, 2004). That longer life, however, brings into view a later chapter that is now among the most intensively studied aspects of the condition.

Alzheimer's Disease and Aging

One of the most consequential facts about Down syndrome is its intimate link to Alzheimer's disease. The gene for the *amyloid precursor protein* (APP), whose fragment forms the amyloid plaques that are a hallmark of Alzheimer pathology, sits on chromosome 21 — and is therefore present in three copies in Down syndrome, producing about 50% more of the protein across the lifespan (Wiseman et al., 2015). The consequence is striking: essentially all adults with Down syndrome develop the neuropathological changes of Alzheimer's disease — amyloid plaques and neurofibrillary tangles — by their 40s, decades earlier than in the general population (Lott & Head, 2019).

The presence of the pathology does not translate immediately into dementia; there is typically a lag of years between the appearance of Alzheimer changes in the brain and the clinical onset of dementia symptoms, and not everyone with the pathology progresses at the same rate (Ballard, Mobley, Hardy, Williams, & Corbett, 2016). But the lifetime risk of dementia is very high, and it has become a leading cause of death in older adults with Down syndrome as life expectancy has risen, making its detection and eventual treatment a central clinical priority (Lott & Head, 2019).

This connection has made Down syndrome pivotal to Alzheimer research far beyond the condition itself. Because trisomy 21 provides a *genetically determined*, near-certain, early-onset form of Alzheimer's disease with a known cause — APP triplication — it offers a natural model in which the disease's earliest, pre-symptomatic stages can be studied prospectively, testing the amyloid hypothesis and potential preventive treatments in a population destined to develop the pathology (Wiseman et al., 2015). What is learned there may inform the understanding of Alzheimer's disease in everyone.

Discussion

The scientific importance of Down syndrome for cognitive psychology rests on a single idea running through everything above: a precisely defined genetic cause produces not a uniform lowering of the mind but a *structured*, dissociable profile of strengths and weaknesses. That structure is evidence, of a kind hard to obtain any other way, that cognition is built from partly independent components. If intelligence were a single quantity, trisomy 21 could only turn it down; the fact that it spares visuospatial memory while impairing verbal memory, spares implicit while impairing explicit memory, shows that these are separable systems with separable neural bases (Silverman, 2007; Vicari et al., 2000).

The condition also became a model for *how* to reason from genes to minds. The biobehavioural strategy — predicting the cognitive profile from the brain systems a disorder affects, then testing the prediction — found in Down syndrome one of its clearest successes, with hippocampal under-development predicting and explaining the selective explicit-memory deficit (Nadel, 2003; Pennington et al., 2003). At the same time, the developmental and neuroconstructivist tradition has insisted that this profile is not innate and static but *emerges* over time from earlier, subtler differences, cautioning against reading an adult profile back into the infant brain (Karmiloff-Smith et al., 2016; Edgin, 2013). Holding both truths — a characteristic profile and a developmental construction of it — is the mature form of the science.

Cognitive Implications

For cognitive psychology, Down syndrome is a standing demonstration that the architecture of the mind is *fractionable*. The double dissociation between verbal and visuospatial short-term memory maps directly onto the components of the working memory model, with the phonological loop selectively impaired — a real-world confirmation, from a genetic condition, of a distinction first drawn from laboratory experiments (Jarrold & Baddeley, 2001). The implicit-versus-explicit memory dissociation does the same for long-term memory, linking spared procedural learning and impaired conscious recollection to distinct neural systems and to the hippocampus in particular (Vicari et al., 2000).

The syndrome-profile approach it exemplifies has become a general method in the study of intelligence and learning disabilities: different genetic conditions produce different cognitive signatures, and comparing them — Down syndrome against Williams syndrome, for instance, whose profile is almost the mirror image — helps establish which cognitive components are genuinely separable and how they relate to underlying brain systems (Silverman, 2007). The practical payoff is educational: recognising that a learner has relative visuospatial and implicit-learning strengths, and specific verbal-memory and expressive-language weaknesses, allows teaching to be built on the strengths rather than defeated by the weaknesses (Grieco et al., 2015).

Current Directions

Much current research is driven by the twin facts of a longer lifespan and the near-universal Alzheimer pathology. Large longitudinal cohorts now track cognition alongside health across the whole adult lifespan, aiming to distinguish the stable intellectual disability from the *decline* that heralds dementia, and to identify the biomarkers — from blood-based amyloid measures to cognitive tests sensitive to early change — that can flag that transition early (Startin et al., 2020; Lott & Head, 2019). Because Down syndrome offers a population certain to develop Alzheimer pathology from a known genetic cause, it has become a preferred setting for prevention trials that could bear on Alzheimer's disease in the wider population (Wiseman et al., 2015).

A second front is the effort to understand *individual variability* and its genetic and environmental sources, moving beyond the average profile to ask why outcomes differ so widely, and a third is the translation of mechanistic work in trisomic mouse models toward possible cognitive treatments (Dierssen, 2012; Karmiloff-Smith et al., 2016). Across all of these, the field increasingly frames Down syndrome not as a fixed deficit to be catalogued but as a developmental trajectory whose course — in language, in memory, and in later cognitive health — might be favourably altered (Edgin, 2013).

Common Misconceptions

“Down syndrome lowers all abilities equally.”

It does not. The defining cognitive feature is an uneven profile: visuospatial short-term memory and receptive vocabulary are relative strengths, while verbal short-term memory and expressive grammar are disproportionately weak (Silverman, 2007; Chapman & Hesketh, 2000).

“Down syndrome is inherited.”

Almost always no. About 95% of cases are free trisomy 21 arising from a chromosome-separation error, not passed down; only the small fraction due to a translocation can be inherited from a carrier parent (Roizen & Patterson, 2003).

“Most children with Down syndrome are born to older mothers.”

Although the per-pregnancy risk rises steeply with maternal age, most affected children are born to mothers under 35, simply because far more births occur in that age group — a base-rate effect (de Graaf et al., 2017).

“Everyone with Down syndrome gets Alzheimer's dementia.”

Nearly all develop the brain pathology of Alzheimer's disease by their 40s because of APP triplication, but the pathology lags the clinical dementia by years and progression varies; pathology is not the same as dementia (Wiseman et al., 2015; Ballard et al., 2016).

Glossary

Amyloid precursor protein (APP).

A protein whose gene lies on chromosome 21; its fragments form the amyloid plaques of Alzheimer's disease, and its triplication in Down syndrome drives near-universal Alzheimer pathology.

Chromosome 21.

The smallest human autosome; the presence of a third copy of it causes Down syndrome, and its several hundred genes are consequently over-expressed.

Cognitive phenotype.

The characteristic profile of cognitive strengths and weaknesses associated with a genetic condition; in Down syndrome, an uneven pattern rather than a uniform deficit.

Down syndrome.

The condition resulting from a third copy of chromosome 21 (trisomy 21); the most common chromosomal cause of intellectual disability.

Explicit memory.

The conscious recollection of facts and events, dependent on the hippocampus; disproportionately impaired in Down syndrome.

Hippocampus.

A medial-temporal brain structure essential to explicit, relational memory; disproportionately reduced in Down syndrome, explaining the selective explicit-memory deficit.

Implicit memory.

Non-conscious learning expressed in skills, habits, and priming; relatively spared in Down syndrome.

Intellectual disability.

Significantly below-average intellectual functioning with limitations in adaptive behaviour, arising in the developmental period; Down syndrome is its most common genetic cause.

Mosaicism.

The form of Down syndrome (about 1–2% of cases) in which only some cells carry the extra chromosome, because nondisjunction occurred after conception.

Nondisjunction.

The failure of a chromosome pair to separate during cell division; the cause of free trisomy 21 and the event whose likelihood rises with maternal age.

Phonological loop.

The component of working memory that briefly holds speech-based information; specifically impaired in Down syndrome, constraining verbal short-term memory and vocabulary learning.

Robertsonian translocation.

A chromosomal rearrangement in which chromosome-21 material attaches to another chromosome; the cause of about 3–4% of Down syndrome cases, some inherited.

Trisomy 21.

The presence of three copies of chromosome 21 instead of two; the genetic cause of Down syndrome.

Visuospatial short-term memory.

The brief retention of visual and spatial information; a relative strength in Down syndrome, contrasting with the weakness in verbal short-term memory.

Key Researchers

Stylianos E. Antonarakis

(living). A medical geneticist at the University of Geneva whose work on the genome of chromosome 21 and gene-dosage effects underlies the modern molecular understanding of Down syndrome; lead author of the 2020 *Nature Reviews Disease Primers* review. ORCID

Mara Dierssen

(living). A neurobiologist at the Centre for Genomic Regulation in Barcelona who studies how trisomy alters neurons and circuits, author of the influential review *Down syndrome: the brain in trisomic mode*. ORCID

John Langdon Down

(1828–1896). The English physician who gave the first systematic clinical description of the condition in 1866, for whom it is named. Wikidata

Christopher Jarrold

(living). A psychologist at the University of Bristol whose experiments dissected the verbal short-term memory deficit in Down syndrome and located it within the working-memory model. ORCID

Annette Karmiloff-Smith

(1938–2016). A developmental psychologist at Birkbeck, University of London, who championed a neuroconstructivist account of Down syndrome, insisting the cognitive profile emerges over development rather than being fixed. Wikidata

Jérôme Lejeune

(1926–1994). The French pediatrician and geneticist who, with Gautier and Turpin, identified the extra copy of chromosome 21 as the cause of Down syndrome in 1959. Wikidata

Brian G. Skotko

(living). A clinical geneticist directing the Down Syndrome Program at Massachusetts General Hospital and Harvard Medical School, whose work spans population prevalence, cognitive-behavioural functioning, and family outcomes. ORCID

Frequently Asked Questions

What causes Down syndrome?

Down syndrome is caused by trisomy 21 — a third copy of chromosome 21. The several hundred genes on that chromosome are then present in three copies rather than two, and the cumulative effect of this extra gene dosage on development produces the condition (Antonarakis et al., 2020).

Is Down syndrome inherited?

Usually not. About 95% of cases are free trisomy 21 arising from a random chromosome-separation error in the egg or sperm. Only the small fraction (3–4%) caused by a Robertsonian translocation can sometimes be inherited from a carrier parent (Roizen & Patterson, 2003).

Does Down syndrome affect all mental abilities equally?

No. It produces an uneven cognitive profile. Visuospatial short-term memory and receptive vocabulary are relative strengths, while verbal short-term memory, expressive grammar, and explicit long-term memory are disproportionately weak (Silverman, 2007).

Why is verbal memory especially affected?

Down syndrome specifically impairs the phonological loop, the working-memory system that briefly holds speech sounds. Because that system supports learning new words and grammar, its weakness both lowers verbal short-term memory and constrains language development (Jarrold & Baddeley, 2001; Jarrold et al., 2002).

How does maternal age relate to Down syndrome?

The per-pregnancy risk rises steeply with maternal age — from well under 1 in 1,000 in the twenties to more than 1 in 100 by the early forties — because the chromosome-separation error becomes more likely in older eggs. But most affected children are still born to younger mothers, who have far more babies overall (de Graaf et al., 2017).

Why is Down syndrome linked to Alzheimer's disease?

The gene for the amyloid precursor protein sits on chromosome 21, so it is present in three copies in Down syndrome, producing extra amyloid across life. As a result, nearly all adults with Down syndrome develop the brain pathology of Alzheimer's disease by their 40s (Wiseman et al., 2015; Lott & Head, 2019).

What is the life expectancy in Down syndrome?

It has risen dramatically with better medical care — from around 25 years in the 1980s to about 60 today — transforming Down syndrome into a lifespan condition and bringing the cognition and health of older adults to the centre of research (Bittles & Glasson, 2004).

Do people with Down syndrome all have the same abilities?

No. The profile describes a central tendency, but there is wide individual variability in language, memory, and adaptive outcomes, shaped by genetic background, health conditions, and environment (Karmiloff-Smith et al., 2016; Startin et al., 2020).

Support Organizations

• National Down Syndrome Society (NDSS) — advocacy, resources, and support for people with Down syndrome and their families in the United States.
• Global Down Syndrome Foundation — funding and advocacy for research and medical care in Down syndrome.
• Down Syndrome Research Foundation UK — supports research and evidence-based resources on cognition and development in Down syndrome.
• National Down Syndrome Congress (NDSC) — information, community, and annual convention for the Down syndrome community.

References

Hattori, M., Fujiyama, A., Taylor, T. D., Watanabe, H., Yada, T., Park, H.-S., … Yaspo, M.-L. (2000). The DNA sequence of human chromosome 21. Nature, 405(6784), 311–319. https://doi.org/10.1038/35012518

Chapman, R. S., & Hesketh, L. J. (2000). Behavioral phenotype of individuals with Down syndrome. Developmental Disabilities Research Reviews, 6(2), 84–95. https://doi.org/10.1002/1098-2779(2000)6:2%3C84::AID-MRDD2%3E3.0.CO;2-P

Vicari, S., Bellucci, S., & Carlesimo, G. A. (2000). Implicit and explicit memory: A functional dissociation in persons with Down syndrome. Neuropsychologia, 38(3), 240–251. https://doi.org/10.1016/S0028-3932(99)00081-0

Jarrold, C., & Baddeley, A. D. (2001). Short-term memory in Down syndrome: Applying the working memory model. Down Syndrome Research and Practice, 7(1), 17–23. https://doi.org/10.3104/reviews.110

Jarrold, C., Baddeley, A. D., & Phillips, C. E. (2002). Verbal short-term memory in Down syndrome: A problem of memory, audition, or speech? Journal of Speech, Language, and Hearing Research, 45(3), 531–544. https://doi.org/10.1044/1092-4388(2002/042)

Roizen, N. J., & Patterson, D. (2003). Down's syndrome. The Lancet, 361(9365), 1281–1289. https://doi.org/10.1016/S0140-6736(03)12987-X

Nadel, L. (2003). Down's syndrome: A genetic disorder in biobehavioral perspective. Genes, Brain and Behavior, 2(3), 156–166. https://doi.org/10.1034/j.1601-183X.2003.00026.x

Pennington, B. F., Moon, J., Edgin, J., Stedron, J., & Nadel, L. (2003). The neuropsychology of Down syndrome: Evidence for hippocampal dysfunction. Child Development, 74(1), 75–93. https://doi.org/10.1111/1467-8624.00522

Bittles, A. H., & Glasson, E. J. (2004). Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Developmental Medicine & Child Neurology, 46(4), 282–286. https://doi.org/10.1017/S0012162204000441

Silverman, W. (2007). Down syndrome: Cognitive phenotype. Developmental Disabilities Research Reviews, 13(3), 228–236. https://doi.org/10.1002/mrdd.20156

Mégarbané, A., Ravel, A., Mircher, C., Sturtz, F., Grattau, Y., Rethoré, M.-O., Delabar, J.-M., & Mobley, W. C. (2009). The 50th anniversary of the discovery of trisomy 21: The past, present, and future of research and treatment of Down syndrome. Genetics in Medicine, 11(9), 611–616. https://doi.org/10.1097/GIM.0b013e3181b2e34c

Dierssen, M. (2012). Down syndrome: The brain in trisomic mode. Nature Reviews Neuroscience, 13(12), 844–858. https://doi.org/10.1038/nrn3314

Edgin, J. O. (2013). Cognition in Down syndrome: A developmental cognitive neuroscience perspective. Wiley Interdisciplinary Reviews: Cognitive Science, 4(3), 307–317. https://doi.org/10.1002/wcs.1221

Grieco, J., Pulsifer, M., Seligsohn, K., Skotko, B., & Schwartz, A. (2015). Down syndrome: Cognitive and behavioral functioning across the lifespan. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 169(2), 135–149. https://doi.org/10.1002/ajmg.c.31439

Wiseman, F. K., Al-Janabi, T., Hardy, J., Karmiloff-Smith, A., Nizetic, D., Tybulewicz, V. L. J., Fisher, E. M. C., & Strydom, A. (2015). A genetic cause of Alzheimer disease: Mechanistic insights from Down syndrome. Nature Reviews Neuroscience, 16(9), 564–574. https://doi.org/10.1038/nrn3983

Ballard, C., Mobley, W., Hardy, J., Williams, G., & Corbett, A. (2016). Dementia in Down's syndrome. The Lancet Neurology, 15(6), 622–636. https://doi.org/10.1016/S1474-4422(16)00063-6

Karmiloff-Smith, A., Al-Janabi, T., D'Souza, H., Groet, J., Massand, E., Mok, K., Startin, C., Fisher, E., Hardy, J., Nizetic, D., Tybulewicz, V., & Strydom, A. (2016). The importance of understanding individual differences in Down syndrome. F1000Research, 5, 389. https://doi.org/10.12688/f1000research.7506.1

de Graaf, G., Buckley, F., Dever, J., & Skotko, B. G. (2017). Estimation of live birth and population prevalence of Down syndrome in nine U.S. states. American Journal of Medical Genetics Part A, 173(10), 2710–2719. https://doi.org/10.1002/ajmg.a.38402

Godfrey, M., & Lee, N. R. (2018). Memory profiles in Down syndrome across development: A review of memory abilities through the lifespan. Journal of Neurodevelopmental Disorders, 10(1), 5. https://doi.org/10.1186/s11689-017-9220-y

Lott, I. T., & Head, E. (2019). Dementia in Down syndrome: Unique insights for Alzheimer disease research. Nature Reviews Neurology, 15(3), 135–147. https://doi.org/10.1038/s41582-018-0132-6

Bull, M. J. (2020). Down syndrome. New England Journal of Medicine, 382(24), 2344–2352. https://doi.org/10.1056/NEJMra1706537

Antonarakis, S. E., Skotko, B. G., Rafii, M. S., Strydom, A., Pape, S. E., Bianchi, D. W., Sherman, S. L., & Reeves, R. H. (2020). Down syndrome. Nature Reviews Disease Primers, 6(1), 9. https://doi.org/10.1038/s41572-019-0143-7

Startin, C. M., Hamburg, S., Hithersay, R., Al-Janabi, T., Mok, K. Y., Hardy, J., & Strydom, A. (2020). Health comorbidities and cognitive abilities across the lifespan in Down syndrome. Journal of Neurodevelopmental Disorders, 12(1), 4. https://doi.org/10.1186/s11689-019-9306-9